Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents - Results from a randomized, controlled, observer-blind phase II study

Welsch, JA; Senders, S; Essink, B; Klein, T; Smolenov, I; Pedotti, P; Barbi, S; Verma, B; Toneatto, D

Welsch, JA (reprint author), PATH, 600 Calif St,14th Floor, San Francisco, CA 94108 USA.

VACCINE, 2018; 36 (35): 5309

Abstract

Background: Neisseria meningitidis serogroups A, B, C, W and Y cause most meningococcal disease worldwide. An investigational MenABCWY vaccine combini......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索